SE8800637D0 - Intermediates and process for preparation of antihypercholesterolemic tetrazole compounds - Google Patents

Intermediates and process for preparation of antihypercholesterolemic tetrazole compounds

Info

Publication number
SE8800637D0
SE8800637D0 SE8800637A SE8800637A SE8800637D0 SE 8800637 D0 SE8800637 D0 SE 8800637D0 SE 8800637 A SE8800637 A SE 8800637A SE 8800637 A SE8800637 A SE 8800637A SE 8800637 D0 SE8800637 D0 SE 8800637D0
Authority
SE
Sweden
Prior art keywords
alkyl
preparation
intermediates
hydrogen
tetrazole compounds
Prior art date
Application number
SE8800637A
Other languages
English (en)
Other versions
SE8800637L (sv
SE504553C2 (sv
Inventor
J J Wright
S-Y Sit
N Balasubramanian
P J Brown
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8800637D0 publication Critical patent/SE8800637D0/sv
Publication of SE8800637L publication Critical patent/SE8800637L/sv
Publication of SE504553C2 publication Critical patent/SE504553C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE8800637A 1987-02-25 1988-02-24 Mellanprodukter och förfaranden för framställning av antihyperkolesterolemiska tetrazolföreningar SE504553C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1855887A 1987-02-25 1987-02-25
US07/151,512 US4898949A (en) 1987-02-25 1988-02-18 Intermediates for the preparation of antihypercholesterolemic tetrazole compounds

Publications (3)

Publication Number Publication Date
SE8800637D0 true SE8800637D0 (sv) 1988-02-24
SE8800637L SE8800637L (sv) 1988-08-26
SE504553C2 SE504553C2 (sv) 1997-03-03

Family

ID=26691250

Family Applications (3)

Application Number Title Priority Date Filing Date
SE8800637A SE504553C2 (sv) 1987-02-25 1988-02-24 Mellanprodukter och förfaranden för framställning av antihyperkolesterolemiska tetrazolföreningar
SE9300977A SE512485C2 (sv) 1987-02-25 1993-03-24 Förfarande för framställning av mellanprodukter avsedda för framställning av antihyperkolesterolemiska medel
SE9300976A SE503201C2 (sv) 1987-02-25 1993-03-24 Tetrazol mellanprodukter för användning för framställning av nya inhibitorer för enzymet HMG-CoA-reduktas

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE9300977A SE512485C2 (sv) 1987-02-25 1993-03-24 Förfarande för framställning av mellanprodukter avsedda för framställning av antihyperkolesterolemiska medel
SE9300976A SE503201C2 (sv) 1987-02-25 1993-03-24 Tetrazol mellanprodukter för användning för framställning av nya inhibitorer för enzymet HMG-CoA-reduktas

Country Status (27)

Country Link
US (1) US4898949A (sv)
JP (1) JP2603284B2 (sv)
KR (1) KR960007167B1 (sv)
CN (1) CN1030077C (sv)
AT (1) AT395588B (sv)
AU (1) AU610562B2 (sv)
BE (1) BE1002115A3 (sv)
CA (1) CA1328269C (sv)
CH (1) CH678182A5 (sv)
DE (1) DE3805789C2 (sv)
DK (2) DK97388A (sv)
ES (1) ES2009547A6 (sv)
FI (1) FI96600C (sv)
FR (1) FR2611201B1 (sv)
GB (1) GB2202845B (sv)
GR (1) GR1000473B (sv)
HU (3) HU201532B (sv)
IE (1) IE61608B1 (sv)
IT (1) IT1216752B (sv)
LU (1) LU87143A1 (sv)
MY (1) MY102290A (sv)
NL (1) NL8800468A (sv)
NO (1) NO178432C (sv)
NZ (1) NZ223621A (sv)
PT (1) PT86821B (sv)
SE (3) SE504553C2 (sv)
YU (1) YU46781B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FI94339C (sv) 1989-07-21 1995-08-25 Warner Lambert Co Förfarande för framställning av farmaceutiskt användbar /R-(R*,R*)/-2-(4-fluorfenyl)- , -dihydroxi-5-(1-metyletyl)-3-fenyl-4-/(fenylamino)karbonyl/-1H-pyrrol-1-heptansyra och farmaceutiskt användbara salter därav
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
JP2001526256A (ja) * 1997-12-19 2001-12-18 ワーナー−ランバート・エクスポート・リミテッド 1,3−ジオールの合成方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
WO1984002131A1 (en) * 1982-11-22 1984-06-07 Sandoz Ag Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
EP0117228B1 (en) * 1983-01-24 1986-11-05 Sandoz Ag Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
KR890001651B1 (ko) * 1984-06-22 1989-05-12 산도즈 파마슈티칼스 코포레이션 메발로노락톤의 피라졸 동족체 및 이의 유도체의 제조방법
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
AU601264B2 (en) * 1987-02-25 1990-09-06 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazole compounds

Also Published As

Publication number Publication date
CN1070642A (zh) 1993-04-07
MY102290A (en) 1992-05-15
YU36488A (en) 1990-02-28
JP2603284B2 (ja) 1997-04-23
SE512485C2 (sv) 2000-03-20
SE9300976D0 (sv) 1993-03-24
SE503201C2 (sv) 1996-04-15
AU610562B2 (en) 1991-05-23
FR2611201A1 (fr) 1988-08-26
HU895124D0 (sv) 1990-01-28
FI880868A0 (sv) 1988-02-24
DK97388A (da) 1988-08-26
FI96600B (sv) 1996-04-15
NO880802D0 (no) 1988-02-24
NO178432C (no) 1996-03-27
YU46781B (sh) 1994-05-10
DE3805789A1 (de) 1988-09-15
IE61608B1 (en) 1994-11-16
GR880100100A (en) 1988-12-16
DE3805789C2 (de) 2001-05-31
IT1216752B (it) 1990-03-08
HU201533B (en) 1990-11-28
PT86821B (pt) 1992-05-29
NL8800468A (nl) 1988-09-16
IT8819526A0 (it) 1988-02-24
FR2611201B1 (fr) 1991-01-11
ES2009547A6 (es) 1989-10-01
GB8804281D0 (en) 1988-03-23
GB2202845A (en) 1988-10-05
ATA46088A (de) 1992-06-15
SE9300977L (sv)
BE1002115A3 (fr) 1990-07-10
GB2202845B (en) 1991-05-22
NO880802L (no) 1988-08-26
DK97388D0 (da) 1988-02-24
HU201534B (en) 1990-11-28
SE9300977D0 (sv) 1993-03-24
FI96600C (sv) 1996-07-25
DK113897A (da) 1997-10-06
HUT47258A (en) 1989-02-28
PT86821A (pt) 1988-03-01
KR880009946A (ko) 1988-10-06
NZ223621A (en) 1991-06-25
GR1000473B (el) 1992-07-30
SE9300976L (sv) 1993-03-24
AT395588B (de) 1993-01-25
IE880502L (en) 1988-08-18
CA1328269C (en) 1994-04-05
AU1213288A (en) 1988-09-01
CN1030077C (zh) 1995-10-18
LU87143A1 (fr) 1988-09-20
NO178432B (no) 1995-12-18
FI880868A (sv) 1988-08-26
KR960007167B1 (ko) 1996-05-29
JPS63290872A (ja) 1988-11-28
SE8800637L (sv) 1988-08-26
CH678182A5 (sv) 1991-08-15
SE504553C2 (sv) 1997-03-03
US4898949A (en) 1990-02-06
HU201532B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
MX9300821A (es) Compuestos hipolipidemicos.
ES8401031A1 (es) Una tetrahidroftalimida.
HUP0203288A2 (hu) Foszfodiészteráz VII inhibitor hatású pirrolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
DE69131325D1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
DK0754682T3 (da) Aminostilbazolderivat og lægemiddel
SE8800637D0 (sv) Intermediates and process for preparation of antihypercholesterolemic tetrazole compounds
DE3572816D1 (de) Pyridazinone inotropic agents
SE8001556L (sv) Tetrahydrobensotiazolylimidazolidinoner
FI933755A (fi) Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater
FI892681A (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
ES545314A0 (es) Procedimiento para la preparacion de un nuevo derivado de lafenil-3 propeno-2 amina
FI864737A0 (fi) Nya basiskt substituerade pyridinfoereningar, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI845095A0 (fi) Aminoimidazolonderivat saosom histamin-h2-antagonister.
MY130817A (en) Herbicides
ES8502699A1 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
FI915025A0 (fi) 8-azabicyklo(3,2,1) oktylalkyltiazolidinoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
IL97289A0 (en) Tetraazaacenaphthylene-3-one derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
SE8302824L (sv) Nya herbicidforeningar
ATE284379T1 (de) Aminderivate
DE3873046D1 (de) N-phenyltetrahydrophthalimide.
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater
DK0614892T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 5-chlorimidazol-4-carbaldehyder
DK0501369T3 (da) Fremgangsmåde til fremstilling af sulfonylisocyanater
FI952243A (sv) Tetrazolderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed